The primary value of placebo controls in clinical trials is the minimization of bias.

Microdosing psychedelics like LSD and psilocybin shows potential for enhancing mental health, creativity, and cognitive ...

A new review of the evidence finds that only a handful of common remedies provide a modest benefit for acute or chronic back ...

The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...

Only around one in every 10 treatments were found to be effective in relieving lower back pain, according to a new study ...

Open-label placebo yielded very modest analgesia in chronic low back pain, with better short- vs long-term outcomes.

Microdosing, or low-dose treatment of psychedelics such as lysergic acid diethylamide (LSD), has gained popularity in recent ...

The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

A new study suggests that only about 1 in 10 common non-surgical and non-invasive treatments for lower back pain are actually ...